Login / Signup

T-cell replete haploidentical stem cell transplantation with low dose anti-thymocyte globulin for relapsed/refractory Ewing sarcoma family tumors.

Hideki SanoKazuhiro MochizukiShogo KobayashiYoshihiro OharaNobuhisa TakahashiShingo KudoKazuhiko IkedaHitoshi OhtoAtsushi Kikuta
Published in: Cancer reports (Hoboken, N.J.) (2021)
In this study, three of the six patients with RR-ESFTs survived for more than one year without relapse, and the treatment toxicity was considered acceptable even for patients who underwent high-intensity pretreatment. TCR-haplo-SCT could be a potential therapeutic option for patients with RR-ESFTs.
Keyphrases